![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PLEKHF1 |
Gene summary for PLEKHF1 |
![]() |
Gene information | Species | Human | Gene symbol | PLEKHF1 | Gene ID | 79156 |
Gene name | pleckstrin homology and FYVE domain containing 1 | |
Gene Alias | APPD | |
Cytomap | 19q12 | |
Gene Type | protein-coding | GO ID | GO:0006914 | UniProtAcc | Q96S99 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79156 | PLEKHF1 | LZE22T | Human | Esophagus | ESCC | 3.09e-02 | 3.31e-01 | 0.068 |
79156 | PLEKHF1 | P1T-E | Human | Esophagus | ESCC | 1.06e-07 | 4.15e-01 | 0.0875 |
79156 | PLEKHF1 | P2T-E | Human | Esophagus | ESCC | 8.57e-10 | 2.40e-01 | 0.1177 |
79156 | PLEKHF1 | P4T-E | Human | Esophagus | ESCC | 8.92e-06 | 1.11e-01 | 0.1323 |
79156 | PLEKHF1 | P5T-E | Human | Esophagus | ESCC | 3.24e-18 | 4.22e-01 | 0.1327 |
79156 | PLEKHF1 | P8T-E | Human | Esophagus | ESCC | 8.18e-17 | 4.36e-01 | 0.0889 |
79156 | PLEKHF1 | P9T-E | Human | Esophagus | ESCC | 3.07e-07 | 1.44e-01 | 0.1131 |
79156 | PLEKHF1 | P11T-E | Human | Esophagus | ESCC | 2.25e-16 | 9.94e-01 | 0.1426 |
79156 | PLEKHF1 | P15T-E | Human | Esophagus | ESCC | 8.45e-20 | 5.25e-01 | 0.1149 |
79156 | PLEKHF1 | P16T-E | Human | Esophagus | ESCC | 1.76e-06 | 1.02e-01 | 0.1153 |
79156 | PLEKHF1 | P17T-E | Human | Esophagus | ESCC | 1.35e-03 | 3.12e-01 | 0.1278 |
79156 | PLEKHF1 | P20T-E | Human | Esophagus | ESCC | 1.69e-11 | 3.20e-01 | 0.1124 |
79156 | PLEKHF1 | P21T-E | Human | Esophagus | ESCC | 6.54e-06 | 1.41e-01 | 0.1617 |
79156 | PLEKHF1 | P22T-E | Human | Esophagus | ESCC | 1.81e-17 | 1.82e-01 | 0.1236 |
79156 | PLEKHF1 | P23T-E | Human | Esophagus | ESCC | 4.04e-08 | 1.24e-01 | 0.108 |
79156 | PLEKHF1 | P24T-E | Human | Esophagus | ESCC | 2.51e-12 | 2.88e-01 | 0.1287 |
79156 | PLEKHF1 | P26T-E | Human | Esophagus | ESCC | 5.30e-08 | 3.69e-02 | 0.1276 |
79156 | PLEKHF1 | P27T-E | Human | Esophagus | ESCC | 2.03e-05 | 5.65e-02 | 0.1055 |
79156 | PLEKHF1 | P31T-E | Human | Esophagus | ESCC | 2.39e-10 | 2.18e-01 | 0.1251 |
79156 | PLEKHF1 | P32T-E | Human | Esophagus | ESCC | 7.50e-06 | 2.08e-01 | 0.1666 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0097193111 | Esophagus | ESCC | intrinsic apoptotic signaling pathway | 222/8552 | 288/18723 | 5.87e-28 | 2.02e-25 | 222 |
GO:2001233111 | Esophagus | ESCC | regulation of apoptotic signaling pathway | 256/8552 | 356/18723 | 4.11e-24 | 1.04e-21 | 256 |
GO:0009896111 | Esophagus | ESCC | positive regulation of catabolic process | 332/8552 | 492/18723 | 4.36e-23 | 9.22e-21 | 332 |
GO:0031331111 | Esophagus | ESCC | positive regulation of cellular catabolic process | 292/8552 | 427/18723 | 8.67e-22 | 1.53e-19 | 292 |
GO:001605014 | Esophagus | ESCC | vesicle organization | 211/8552 | 300/18723 | 2.85e-18 | 2.87e-16 | 211 |
GO:001050617 | Esophagus | ESCC | regulation of autophagy | 220/8552 | 317/18723 | 6.72e-18 | 6.36e-16 | 220 |
GO:2001242111 | Esophagus | ESCC | regulation of intrinsic apoptotic signaling pathway | 128/8552 | 164/18723 | 1.75e-17 | 1.50e-15 | 128 |
GO:0072659110 | Esophagus | ESCC | protein localization to plasma membrane | 193/8552 | 284/18723 | 1.95e-14 | 1.03e-12 | 193 |
GO:199077819 | Esophagus | ESCC | protein localization to cell periphery | 217/8552 | 333/18723 | 4.08e-13 | 1.88e-11 | 217 |
GO:2001235110 | Esophagus | ESCC | positive regulation of apoptotic signaling pathway | 92/8552 | 126/18723 | 3.91e-10 | 1.05e-08 | 92 |
GO:000703214 | Esophagus | ESCC | endosome organization | 61/8552 | 82/18723 | 1.13e-07 | 1.85e-06 | 61 |
GO:001050816 | Esophagus | ESCC | positive regulation of autophagy | 81/8552 | 124/18723 | 7.74e-06 | 7.65e-05 | 81 |
GO:200124417 | Esophagus | ESCC | positive regulation of intrinsic apoptotic signaling pathway | 43/8552 | 58/18723 | 9.86e-06 | 9.37e-05 | 43 |
GO:000989622 | Liver | HCC | positive regulation of catabolic process | 335/7958 | 492/18723 | 3.83e-31 | 1.87e-28 | 335 |
GO:003133122 | Liver | HCC | positive regulation of cellular catabolic process | 295/7958 | 427/18723 | 3.20e-29 | 1.45e-26 | 295 |
GO:001050621 | Liver | HCC | regulation of autophagy | 210/7958 | 317/18723 | 7.59e-18 | 8.45e-16 | 210 |
GO:200123322 | Liver | HCC | regulation of apoptotic signaling pathway | 226/7958 | 356/18723 | 7.26e-16 | 5.68e-14 | 226 |
GO:001605021 | Liver | HCC | vesicle organization | 194/7958 | 300/18723 | 5.58e-15 | 3.97e-13 | 194 |
GO:009719322 | Liver | HCC | intrinsic apoptotic signaling pathway | 184/7958 | 288/18723 | 1.50e-13 | 8.32e-12 | 184 |
GO:007265921 | Liver | HCC | protein localization to plasma membrane | 177/7958 | 284/18723 | 1.02e-11 | 4.18e-10 | 177 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PLEKHF1 | SNV | Missense_Mutation | c.805N>A | p.Ala269Thr | p.A269T | Q96S99 | protein_coding | tolerated(0.72) | benign(0) | TCGA-BG-A222-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
PLEKHF1 | SNV | Missense_Mutation | c.412N>T | p.Gly138Cys | p.G138C | Q96S99 | protein_coding | deleterious(0) | probably_damaging(0.976) | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
PLEKHF1 | SNV | Missense_Mutation | novel | c.104N>C | p.Val35Ala | p.V35A | Q96S99 | protein_coding | deleterious(0.03) | possibly_damaging(0.566) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
PLEKHF1 | SNV | Missense_Mutation | novel | c.158N>A | p.Arg53His | p.R53H | Q96S99 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-E6-A2P8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | PD |
PLEKHF1 | SNV | Missense_Mutation | novel | c.158G>A | p.Arg53His | p.R53H | Q96S99 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-EC-A24G-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD |
PLEKHF1 | SNV | Missense_Mutation | novel | c.356N>A | p.Arg119His | p.R119H | Q96S99 | protein_coding | deleterious(0) | probably_damaging(0.98) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD |
PLEKHF1 | deletion | Frame_Shift_Del | c.240delN | p.Leu82TrpfsTer20 | p.L82Wfs*20 | Q96S99 | protein_coding | TCGA-AJ-A2QO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |||
PLEKHF1 | SNV | Missense_Mutation | c.209N>G | p.Asn70Ser | p.N70S | Q96S99 | protein_coding | tolerated(0.64) | benign(0.012) | TCGA-44-A4SS-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
PLEKHF1 | SNV | Missense_Mutation | novel | c.356N>A | p.Arg119His | p.R119H | Q96S99 | protein_coding | deleterious(0) | probably_damaging(0.98) | TCGA-55-7914-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | PD |
PLEKHF1 | SNV | Missense_Mutation | novel | c.409N>T | p.Thr137Ser | p.T137S | Q96S99 | protein_coding | tolerated(1) | benign(0.023) | TCGA-33-A5GW-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |